Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

Increase the proportion of people on Medicare with chronic kidney disease who get recommended tests — CKD‑04 Data

National Status: Improving

  

Most Recent Data:
39.8 percent (2023)

National Target:
48.3 percent  1

Desired Direction:
Increase desired

National Baseline:
35.6 percent of Medicare beneficiaries aged 65 years and over with chronic kidney disease received medical evaluation with serum creatinine, lipids, and urine albumin tests in 2016 2

Disparities data are only available for some selections.

View CI in the chart by hovering over a data point.

View SE in the chart by hovering over a data point.

Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available

Display data for:

Persons with chronic kidney disease receiving medical evaluation, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
Total
35.6
CI 35.4 / 35.8
SE 0.120
35.8
CI 35.6 / 36.1
SE 0.116
35.9
CI 35.7 / 36.1
SE 0.114
36.4
CI 36.1 / 36.6
SE 0.111
35.5
CI 35.3 / 35.8
SE 0.113
36.9
CI 36.7 / 37.2
SE 0.111
37.8
CI 37.6 / 38.0
SE 0.110
39.8
CI 39.6 / 40.1
SE 0.110

Persons with chronic kidney disease receiving medical evaluation by Sex, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
Male
37.2
CI 36.9 / 37.5
SE 0.172
37.0
CI 36.7 / 37.4
SE 0.166
37.3
CI 37.0 / 37.6
SE 0.162
37.7
CI 37.4 / 38.0
SE 0.158
36.9
CI 36.6 / 37.2
SE 0.161
38.2
CI 37.9 / 38.5
SE 0.158
39.1
CI 38.8 / 39.4
SE 0.158
41.1
CI 40.8 / 41.4
SE 0.157
Female
34.1
CI 33.7 / 34.4
SE 0.166
34.7
CI 34.4 / 35.0
SE 0.162
34.5
CI 34.2 / 34.8
SE 0.159
35.0
CI 34.7 / 35.3
SE 0.155
34.2
CI 33.9 / 34.5
SE 0.158
35.7
CI 35.4 / 36.0
SE 0.155
36.6
CI 36.3 / 36.9
SE 0.154
38.7
CI 38.4 / 39.0
SE 0.154

Persons with chronic kidney disease receiving medical evaluation by Race/Ethnicity, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
American Indian or Alaska Native
25.0
CI 21.9 / 28.1
SE 1.571
23.2
CI 20.4 / 26.1
SE 1.462
23.8
CI 21.0 / 26.7
SE 1.436
23.9
CI 21.2 / 26.6
SE 1.389
25.3
CI 22.4 / 28.2
SE 1.498
24.3
CI 21.4 / 27.2
SE 1.482
24.3
CI 21.4 / 27.3
SE 1.524
26.4
CI 23.2 / 29.5
SE 1.596
Asian
46.2
CI 44.5 / 47.9
SE 0.876
47.4
CI 45.7 / 49.0
SE 0.842
48.2
CI 46.6 / 49.8
SE 0.820
48.8
CI 47.2 / 50.4
SE 0.804
48.0
CI 46.4 / 49.7
SE 0.835
50.9
CI 49.3 / 52.4
SE 0.804
52.1
CI 50.6 / 53.7
SE 0.783
53.9
CI 52.4 / 55.4
SE 0.782
Black or African American
37.4
CI 36.7 / 38.1
SE 0.375
38.5
CI 37.8 / 39.2
SE 0.371
37.9
CI 37.2 / 38.6
SE 0.369
39.0
CI 38.3 / 39.7
SE 0.366
38.6
CI 37.9 / 39.4
SE 0.381
40.9
CI 40.2 / 41.7
SE 0.387
42.3
CI 41.5 / 43.1
SE 0.394
44.7
CI 43.9 / 45.4
SE 0.396
White
34.7
CI 34.4 / 34.9
SE 0.130
34.8
CI 34.6 / 35.1
SE 0.126
34.9
CI 34.7 / 35.2
SE 0.124
35.3
CI 35.1 / 35.6
SE 0.120
34.4
CI 34.2 / 34.7
SE 0.123
35.8
CI 35.5 / 36.0
SE 0.120
36.6
CI 36.3 / 36.8
SE 0.119
38.6
CI 38.3 / 38.8
SE 0.119
Hispanic or Latino
46.2
CI 44.3 / 48.1
SE 0.989
46.2
CI 44.3 / 48.1
SE 0.965
45.8
CI 43.9 / 47.6
SE 0.966
47.0
CI 45.1 / 48.9
SE 0.957
44.6
CI 42.6 / 46.5
SE 1.006
47.0
CI 45.0 / 49.0
SE 1.028
46.8
CI 44.7 / 48.8
SE 1.027
49.4
CI 47.3 / 51.4
SE 1.052

Persons with chronic kidney disease receiving medical evaluation by Age group, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
65-74 years
43.8
CI 43.4 / 44.2
SE 0.199
43.2
CI 42.8 / 43.6
SE 0.191
43.1
CI 42.7 / 43.4
SE 0.187
43.0
CI 42.7 / 43.4
SE 0.182
41.8
CI 41.5 / 42.2
SE 0.184
42.8
CI 42.4 / 43.1
SE 0.179
43.7
CI 43.3 / 44.0
SE 0.181
45.9
CI 45.6 / 46.3
SE 0.183
75-84 years
36.4
CI 36.0 / 36.8
SE 0.194
36.7
CI 36.4 / 37.1
SE 0.189
36.8
CI 36.5 / 37.2
SE 0.184
37.4
CI 37.1 / 37.8
SE 0.179
36.6
CI 36.3 / 37.0
SE 0.182
38.1
CI 37.8 / 38.5
SE 0.178
39.0
CI 38.7 / 39.4
SE 0.175
41.3
CI 40.9 / 41.6
SE 0.171
85 years and over
20.6
CI 20.2 / 21.0
SE 0.211
21.3
CI 20.9 / 21.7
SE 0.210
21.4
CI 21.0 / 21.8
SE 0.207
22.2
CI 21.8 / 22.6
SE 0.206
21.4
CI 21.0 / 21.8
SE 0.213
23.3
CI 22.8 / 23.7
SE 0.214
24.3
CI 23.8 / 24.7
SE 0.215
25.9
CI 25.5 / 26.3
SE 0.217

Persons with chronic kidney disease receiving medical evaluation by Educational attainment, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
Educational attainment
DNC
DNC
DNC
DNC
DNC
DNC
DNC
DNC

Persons with chronic kidney disease receiving medical evaluation by Family income, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
Family income
DNC
DNC
DNC
DNC
DNC
DNC
DNC
DNC

Persons with chronic kidney disease receiving medical evaluation by Geographic location, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
Geographic location
DNC
DNC
DNC
DNC
DNC
DNC
DNC
DNC

Persons with chronic kidney disease receiving medical evaluation by Marital status, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
Marital status
DNC
DNC
DNC
DNC
DNC
DNC
DNC
DNC

Persons with chronic kidney disease receiving medical evaluation by Country of birth, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
Country of birth
DNC
DNC
DNC
DNC
DNC
DNC
DNC
DNC

Persons with chronic kidney disease receiving medical evaluation by Veteran status, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
Veteran status
DNC
DNC
DNC
DNC
DNC
DNC
DNC
DNC

Persons with chronic kidney disease receiving medical evaluation by Disability status, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
Disability status
DNC
DNC
DNC
DNC
DNC
DNC
DNC
DNC

Persons with chronic kidney disease receiving medical evaluation by Sexual orientation, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
Sexual orientation
DNC
DNC
DNC
DNC
DNC
DNC
DNC
DNC

Persons with chronic kidney disease receiving medical evaluation by Gender identity, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
Gender identity
DNC
DNC
DNC
DNC
DNC
DNC
DNC
DNC

Persons with chronic kidney disease receiving medical evaluation by Diabetes status, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
With diabetes
52.1
CI 51.8 / 52.5
SE 0.177
52.8
CI 52.4 / 53.1
SE 0.172
52.7
CI 52.4 / 53.1
SE 0.169
53.8
CI 53.4 / 54.1
SE 0.165
52.6
CI 52.2 / 52.9
SE 0.170
54.9
CI 54.6 / 55.2
SE 0.167
55.8
CI 55.4 / 56.1
SE 0.165
58.4
CI 58.1 / 58.7
SE 0.163
Without diabetes
19.3
CI 19.0 / 19.5
SE 0.139
19.2
CI 19.0 / 19.5
SE 0.134
19.7
CI 19.5 / 20.0
SE 0.132
19.9
CI 19.7 / 20.2
SE 0.128
19.8
CI 19.6 / 20.1
SE 0.131
21.0
CI 20.8 / 21.3
SE 0.129
22.1
CI 21.8 / 22.3
SE 0.129
24.0
CI 23.7 / 24.2
SE 0.131

Persons with chronic kidney disease receiving medical evaluation by High blood pressure status, 2016-2023 ◊
(percent)
Increase desired

Population 2016 2017 2018 2019 2020 2021 2022 2023
With high blood pressure
36.7
CI 36.4 / 36.9
SE 0.126
37.0
CI 36.8 / 37.2
SE 0.122
37.1
CI 36.9 / 37.3
SE 0.120
37.6
CI 37.4 / 37.8
SE 0.117
36.9
CI 36.7 / 37.2
SE 0.120
38.4
CI 38.2 / 38.7
SE 0.118
39.4
CI 39.1 / 39.6
SE 0.118
41.5
CI 41.3 / 41.7
SE 0.117
Without high blood pressure
23.5
CI 22.8 / 24.2
SE 0.372
23.3
CI 22.6 / 24.0
SE 0.354
23.2
CI 22.5 / 23.8
SE 0.342
23.5
CI 22.9 / 24.2
SE 0.331
23.1
CI 22.5 / 23.7
SE 0.314
23.6
CI 23.0 / 24.2
SE 0.307
24.7
CI 24.1 / 25.3
SE 0.303
26.3
CI 25.7 / 26.9
SE 0.301

Disparity